1800 22. EuroQol Group (1990) EuroQol—a new facility for the mea- surement of health-related quality of life. Health Policy 20(3):321–328 23. Ware J, Kosinski M, Turner-Bowker D, Gandek B (2002) SF12v2: how to score version 2 of the SF-12 health survey. QualityMetric Incorporated, Lincoln 24. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174 25. Kind P, Dolan P, Gudex C, Williams A (1998) Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 316(7133):736–741 26. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B (2002) User’s manual for the SF-12v2 health survey with a supplement documenting SF-12 health survey. QualityMetric Incorporated, Lincoln 27. Aubeeluck A, Buchanan H (2007) The Huntington’s disease quality of life battery for carers: reliability and validity. Clin Genet 71(5):434–445 28. Kaptein AA, Scharloo M, Helder DI, Snoei L, van Kempen GM, Weinman J et al (2007) Quality of life in couples living with Huntington’s disease: the role of patients’ and partners’ illness perceptions. Qual Life Res 16(5):793–801 29. McCabe MP, Firth L, O’Connor E (2009) A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers. J Clin Psychol Med Settings 16(4):355–362 30. Pickard AS, Knight SJ (2005) Proxy evaluation of health-related quality of life: a conceptual framework for understanding mul- tiple proxy perspectives. Med Care 43(5):493–499 J Neurol (2012) 259:1793–1800 31. Hilari K, Owen S, Farrelly SJ (2007) Proxy and self-report agreement on the stroke and aphasia quality of life scale-39. J Neurol Neurosurg Psychiatr 78(10):1072–1075 32. Sneeuw KCA, Aaronson NK, Osoba D, Muller MJ, Hsu M-A, Yung A et al (1997) The use of signiﬁcant others as proxy raters of the quality of life of patients with brain cancer. Med Care 35(5):490–506 33. Sneeuw KC, Sprangers MA, Aaronson NK (2002) The role of health care providers and signiﬁcant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol 55(11):1130–1143 34. Andresen EM, Vahle VJ, Lollar D (2001) Proxy reliability: health-related quality of life (HrQoL) measures for people with disability. Qual Life Res 10(7):609–619 35. Mahant N, McCusker EA, Byth K, Graham S (2003) Hunting- ton’s disease: clinical correlates of disability and progression. Neurology 61(8):1085–1092 36. Ho AK, Hocaoglu MB, European Huntington’s Disease Network Quality of Life Working Group (2011) Impact of Huntington dis- ease across the entire disease spectrum: the phases and stages of disease from the patient perspective. Clin Genet 80(3):235–239 37. Rothman ML, Hedrick SC, Bulcroft KA, Hickam DH, Ruben- stein LZ (1991) The validity of proxy-generated scores as mea- sures of patient health status. Med Care 29(2):115–124 38. Magaziner J (1997) Use of proxies to measure health and func- tional outcomes in effectiveness research in persons with Alz- heimer disease and related disorders. Alzheimer Dis Assoc Disord 11(Suppl 6):168–174 39. von Essen L (2004) Proxy ratings of patient quality of life. Acta Oncol 43(3):229–234 123